Literature DB >> 17416965

Gi and RGS proteins provide biochemical control of androgen receptor nuclear exclusion.

Avi Rimler1, Ralf Jockers, Zipora Lupowitz, Nava Zisapel.   

Abstract

Nuclear localization of androgen receptors (ARs) is essential for their activity. Melatonin induces AR nuclear exclusion via increase in cGMP, calcium, and protein kinase C (PKC) activation, presumably through G-protein(s). The effects of regulators of G-protein signaling (RGS) on AR localization were studied in AR-expressing PC3 cells. Gi-specific RGS10 inhibited melatonin but not cGMP-induced AR nuclear exclusion, independent of androgen. No evidence for Gq activation by melatonin was found. However, Gi/Gq-selective RGS4 inhibited AR nuclear exclusion downstream of PKC activation--an effect that was abrogated by constitutively active Gq. RGS10 and RGS4, but not RGS2, ablated the inhibitory effects of melatonin on AR reporter gene activity. For the first time, these data show regulation by Gi and Gi-specific RGS protein-mediated AR nuclear exclusion, which is potentially important in the treatment of AR-dependent cancers and neurodegenerative disorders. They also reveal a role for a Gq protein downstream of PKC activation in AR nuclear localization.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17416965     DOI: 10.1007/bf02686113

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  29 in total

1.  Phosphorylation and nuclear translocation of a regulator of G protein signaling (RGS10).

Authors:  P G Burgon; W L Lee; A B Nixon; E G Peralta; P J Casey
Journal:  J Biol Chem       Date:  2001-07-06       Impact factor: 5.157

Review 2.  Melatonin receptors step into the light: cloning and classification of subtypes.

Authors:  S M Reppert; D R Weaver; C Godson
Journal:  Trends Pharmacol Sci       Date:  1996-03       Impact factor: 14.819

3.  RGS family members: GTPase-activating proteins for heterotrimeric G-protein alpha-subunits.

Authors:  N Watson; M E Linder; K M Druey; J H Kehrl; K J Blumer
Journal:  Nature       Date:  1996-09-12       Impact factor: 49.962

4.  Novel isoforms of Mel1c melatonin receptors modulating intracellular cyclic guanosine 3',5'-monophosphate levels.

Authors:  R Jockers; L Petit; I Lacroix; P de Coppet; P Barrett; P J Morgan; B Guardiola; P Delagrange; S Marullo; A D Strosberg
Journal:  Mol Endocrinol       Date:  1997-07

Review 5.  Androgen receptor: structural domains and functional dynamics after ligand-receptor interaction.

Authors:  A K Roy; R K Tyagi; C S Song; Y Lavrovsky; S C Ahn; T S Oh; B Chatterjee
Journal:  Ann N Y Acad Sci       Date:  2001-12       Impact factor: 5.691

6.  G protein selectivity is a determinant of RGS2 function.

Authors:  S P Heximer; S P Srinivasa; L S Bernstein; J L Bernard; M E Linder; J R Hepler; K J Blumer
Journal:  J Biol Chem       Date:  1999-11-26       Impact factor: 5.157

7.  Melatonin receptors in PC3 human prostate tumor cells.

Authors:  E Gilad; M Laufer; H Matzkin; N Zisapel
Journal:  J Pineal Res       Date:  1999-05       Impact factor: 13.007

8.  Differential regulation by melatonin of cell growth and androgen receptor binding to the androgen response element in prostate cancer cells.

Authors:  Avi Rimler; Zippora Lupowitz; Nava Zisapel
Journal:  Neuro Endocrinol Lett       Date:  2002-04       Impact factor: 0.765

9.  Protein kinase C phosphorylates RGS2 and modulates its capacity for negative regulation of Galpha 11 signaling.

Authors:  M L Cunningham; G L Waldo; S Hollinger; J R Hepler; T K Harden
Journal:  J Biol Chem       Date:  2000-11-03       Impact factor: 5.157

10.  Melatonin elicits nuclear exclusion of the human androgen receptor and attenuates its activity.

Authors:  A Rimler; Z Culig; G Levy-Rimler; Z Lupowitz; H Klocker; H Matzkin; G Bartsch; N Zisapel
Journal:  Prostate       Date:  2001-10-01       Impact factor: 4.104

View more
  3 in total

1.  Melatonin potentiates rod signals to ON type bipolar cells in fish retina.

Authors:  Yong Ping; Hai Huang; Xin-Jun Zhang; Xiong-Li Yang
Journal:  J Physiol       Date:  2008-04-03       Impact factor: 5.182

Review 2.  The inhibitory effect of melatonin on human prostate cancer.

Authors:  Dexin Shen; Lingao Ju; Fenfang Zhou; Mengxue Yu; Haoli Ma; Yi Zhang; Tongzu Liu; Yu Xiao; Xinghuan Wang; Kaiyu Qian
Journal:  Cell Commun Signal       Date:  2021-03-15       Impact factor: 5.712

Review 3.  The melatonergic system in mood and anxiety disorders and the role of agomelatine: implications for clinical practice.

Authors:  Domenico De Berardis; Stefano Marini; Michele Fornaro; Venkataramanujam Srinivasan; Felice Iasevoli; Carmine Tomasetti; Alessandro Valchera; Giampaolo Perna; Maria-Antonia Quera-Salva; Giovanni Martinotti; Massimo di Giannantonio
Journal:  Int J Mol Sci       Date:  2013-06-13       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.